Details
Mildronate Indications
- complex therapy of ischemic heart disease (angina, myocardial infarction), congestive heart failure, cardiomyopathy dyshormonal;
- complex therapy of acute and chronic cerebrovascular events (stroke, cerebrovascular insufficiency);
- hemophthalmus and retinal hemorrhages of different etiologies, thrombosis of the central retinal vein and its branches, retinopathy of different etiology (diabetic, hypertensive);
- reduced working capacity; physical overload, including the athletes;
- complex therapy of patients with withdrawal syndrome, and chronic alcoholism.
Dosage & Administration
Cardiovascular diseases. Inside of 0.5-1 g / d or / (5-10 ml solution of injection of 0.5 g / 5 mL), once or in 2 hours. The course of treatment - 4-6 weeks.
Dishormonal dystrophy infarction cardialgia - inside of 0.25 g 2 times a day. The course of treatment - 12 days.
Violations of the cerebral circulation. Acute phase - in / 0.5 1 g once daily for 10 days, then - the interior of 0.5-1 g / day. The course of treatment - 4-6 weeks.
Chronic disorders of cerebral circulation - inside of 0.5-1 g / day. The course of treatment - 4-6 weeks. Repeated courses (usually 2-3 times a year) - on doctor's orders.
Vascular disorders and degenerative diseases of the retina. Parabulbarno 0.5 ml solution of injection of 0.5 g / 5 ml for 10 days.
Significant mental and physical activity, including the athletes. Adults - 0.25 g orally 4 times a day or 0.5 g / 1 time per day. The course of treatment - 10-14 days. If necessary, repeat the treatment after 2-3 weeks.
Athletes by 0.5-1 g orally 2 times a day before training. The duration of the preparatory period - 14-21 days, during the period of competition - 10-14 days.
Chronic alcoholism. Inside of 0.5 g 4 times a day; w / w - 0,5 g 2 times per day. The course of treatment 7-10 days.
Contradictions
Hypersensitivity to the drug, increased intracranial pressure (in violation of the venous outflow, intracranial tumors).
Pregnancy and breast-feeding, age up to 12 years.
